AN2 Therapeutics, Inc.ANTXNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-29.83M
Near historical average
Percentile
P50
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-27.74M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-29.83M | +39.4% |
| 2024 | $-49.26M | +7.6% |
| 2023 | $-53.29M | -59.2% |
| 2022 | $-33.46M | -63.4% |
| 2021 | $-20.48M | -281.9% |
| 2020 | $-5.36M | -115.8% |
| 2019 | $-2.49M | - |